SCHEMBL19500801

SCHEMBL19500801

c1ccc(-c2ccc(-n3c4ccccc4c4ccc(-c5ccc(-c6ccc7c8ccccc8n(-c8ccc9cc(-c%10ccccc%10)ccc9c8)c7c6)cc5)cc43)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ATM Q13315 1/20 0.50
HDAC4 P56524 1/20 0.41
ESR1 P03372 5/20 0.41
ESR2 Q92731 5/20 0.41
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
LDHA P00338 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
HSP90AA1 P07900 1/20 0.37
NR3C1 P04150 1/20 0.37
PTPN1 P18031 1/20 0.36
PGR P06401 1/20 0.36
IL1R1 P14778 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19500797 0.98 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL12699666 0.97 KDM4E (0.48) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500787 0.96 KDM4E (0.46) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500770 0.96 KDM4E (0.46) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19036992 0.95 KDM4E (0.49) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500800 0.95 KDM4E (0.44) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500798 0.95 KDM4E (0.49) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500782 0.94 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500781 0.94 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4ESR1
SCHEMBL19500802 0.94 ATM (0.47) L3MBTL1KDM4EATMHDAC4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633583-B2 Organic electroluminescent compounds and an organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2020-04-28 US disclosed
US-20170305854-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-10-26 US disclosed
US-20170305854-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305854-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OTC, TELO2, TERT L3MBTL1 251/4885KDM4E 780/4885ATM 1755/4885
US-10633583-B2 Organic electroluminescent compounds and an organic electroluminescent device comprising the same ELAVL1, OTC, SOD1 L3MBTL1 190/4885KDM4E 906/4885ATM 1861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.